Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
What is the purpose of this study?
The purpose of this protocol is to find the biochemical and genetic causes of inherited immune diseases affecting lymphocytes. A second purpose is to develop new knowledge which will help research doctors find better ways to prevent, diagnosis, and treat these inherited immune diseases.
- Cancer - Immune Deficiency and Histiocytosis
- Human Genetics
Will I get all the facts about the study?
If you are interested in participating in this study, you will meet with a study coordinator who will explain all of the details of the study. The study coordinator will review the consent form and will be sure that all questions are answered. The consent form describes all the procedures, risks, benefits and who to contact with questions or concerns. Study procedures will not begin until the consent has been signed by the patient (if over 18 years) or the parent/guardian of the patient.
What are the risks and discomforts of the study?
A detailed list of possible risks will be provided to those patients interested in knowing more about the study.
Who should I contact for more information?
Tashia L. Harris, MS
Clinical Research Coordinator IV
Cancer and Blood Diseases Institute
Cincinnati Children's Hospital Medical Center
MLC 11027, 3333 Burnet Avenue
Cincinnati, Ohio 45229-3039
Where can I find additional information?